Meeting
2012 ASCO Annual Meeting
Breast cancer intrinsic subtypes by PAM50 in older women.
Authors
Emily Oldham Jenkins
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Emily Oldham Jenkins , Allison Mary Deal , Carey K. Anders , Aleix Prat , Charles M. Perou , Lisa A. Carey , Hyman Bernard Muss
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Cancer Genetics
Citation
J Clin Oncol 30, 2012 (suppl; abstr 1524)
DOI
10.1200/jco.2012.30.15_suppl.1524
Abstract #
1524
Poster Bd #
13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Gene expression profiling of paired primary breast cancers and brain metastases to identify brain metastases-specific biological changes.
First Author: Gaia Griguolo
Poster
2016 ASCO Annual Meeting
Prospective multicenter study of the impact of the Prosigna assay on adjuvant clinical decision-making in women with early stage breast cancer: which patients are the best candidates?
First Author: Roman Rouzier
Poster
2023 ASCO Annual Meeting
HER2-low breast cancer brain metastases: Incidence and treatment implications.
First Author: Rania Chehade
Poster
2017 ASCO Annual Meeting
Association of molecular subtype, proliferation, and immune genes with efficacy of carboplatin versus gemcitabine addition to taxane-based, anthracycline-free neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Results of the randomized WSG ADAPT-TN trial.
First Author: Oleg Gluz